The lancet oncology
-
The lancet oncology · Jul 2022
Impact of geospatial barriers on breast cancer care in Haiti: a retrospective cohort study.
Although geospatial barriers to cancer care are recognised, data quantifying their magnitude and impact on treatment and outcomes in low-income and middle-income countries are scarce. The objective of this study was to describe the geospatial distribution of patients receiving care for breast cancer at a tertiary hospital in Haiti. ⋯ Center for Global Cancer Medicine, Dana-Farber Cancer Institute, Boston, MA, USA.
-
The lancet oncology · Jul 2022
Observational StudyPlace of death of people with cancer in 12 Latin American countries: a total population study using national death registers.
Cancer is the second leading cause of death in almost all Latin American countries. Knowing where people with cancer die and understanding the factors that affect where they die are public health issues, relevant for the development of policies that ensure the provision of adequate end-of-life care in alignment with patients' needs and preferences. The objective of this study was to describe and compare the place of death of people with cancer in 12 Latin American countries, and explore associated factors. ⋯ None.
-
The lancet oncology · Jul 2022
Impact of integrated palliative care in acute and aggressive medical care for patients with advanced haematological malignancies: a retrospective matched case-control study.
Aggressive medical care can increase suffering and the health-care burden on patients with advanced haematological malignancies. Our palliative care team has been pioneering an integrated palliative care (IPC) programme for patients with advanced haematological malignancies in Hong Kong since 2018. The aim of the study was to evaluate the effect of IPC on the administration of chemotherapy or other treatments within the 14 days before death; multiple (more than one) emergency department visits within the 90 days before death; multiple (more than one) unplanned hospitalisations within the 90 days before death; and intensive care unit admission within the 90 days before death. ⋯ None.
-
The lancet oncology · Jul 2022
Impact of COVID-19 pandemic on breast cancer care: report from a regional cancer centre.
The COVID-19 pandemic has deeply disrupted cancer care, both during and after lockdowns. In this study, we analysed the treatment delay in patients with breast cancer due to COVID-19 pandemic in India. ⋯ None.
-
The lancet oncology · Jul 2022
Serious health-related suffering in Latin America: a secondary analysis.
Evidence from needs analysis can support health systems and improve morbidity and mortality rates related to life-limiting and life-threatening conditions, and is essential for the development of health care and educational plans to respond adequately to the disease burden of the population. The aim of this study was to establish the number of people with serious health-related suffering, defined as a negative impact on the functioning (eg, physical, social, or emotional) of a patient with a serious illness that cannot be mitigated without medical intervention, in 19 Spanish-speaking and Portuguese-speaking Latin American countries in 1990, 2000, 2010, and 2019. ⋯ None.